Evoke Wealth’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Hold |
133,122
| – | – | ﹤0.01% | 563 |
|
|
2025
Q1 | $145K | Hold |
133,122
| – | – | ﹤0.01% | 435 |
|
|
2024
Q4 | $201K | Hold |
133,122
| – | – | 0.01% | 410 |
|
|
2024
Q3 | $198K | Buy |
133,122
+69,889
| +111% | +$104K | 0.01% | 396 |
|
|
2024
Q2 | $102K | Buy |
+63,233
| New | +$102K | 0.12% | 94 |
|
|
2023
Q1 | – | Sell |
-133,122
| Closed | -$1.16M | – | 369 |
|
|
2022
Q4 | $1.16M | Hold |
133,122
| – | – | 0.04% | 149 |
|
|
2022
Q3 | $1.58M | Hold |
133,122
| – | – | 0.06% | 115 |
|
|
2022
Q2 | $1.9M | Buy |
133,122
+101,208
| +317% | +$1.44M | 0.07% | 112 |
|
|
2022
Q1 | $664K | Hold |
31,914
| – | – | 0.02% | 205 |
|
|
2021
Q4 | $737K | Buy |
+31,914
| New | +$737K | 0.02% | 206 |
|
|
2021
Q3 | – | Sell |
-3,403
| Closed | -$116K | – | 1202 |
|
|
2021
Q2 | $116K | Buy |
+3,403
| New | +$116K | ﹤0.01% | 414 |
|